Wed, July 22, 2020
Tue, July 21, 2020
Mon, July 20, 2020
Sun, July 19, 2020
Fri, July 17, 2020
Thu, July 16, 2020
Wed, July 15, 2020

Raghuram Selvaraju Maintained (BTAI) at Strong Buy with Increased Target to $200 on, Jul 20th, 2020


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. th-increased-target-to-200-on-jul-20th-2020.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Raghuram Selvaraju of HC Wainwright & Co., Maintained "BioXcel Therapeutics, Inc." (BTAI) at Strong Buy with Increased Target from $120 to $200 on, Jul 20th, 2020.

Raghuram has made no other calls on BTAI in the last 4 months.



There is 1 other peer that has a rating on BTAI. Out of the 1 peers that are also analyzing BTAI, 0 agree with Raghuram's Rating of Hold.



This is the rating of the analyst that currently disagrees with Raghuram


  • Geoff Meacham of "B of A Securities" Reiterated at Strong Buy with Increased Target to $63 on, Monday, July 13th, 2020

Publication Contributing Sources

Similar Stocks and Investing Publications